SCHEMBL9684073

SCHEMBL9684073

C/C(=C\C(=O)O)c1ccc(C[C@@H](C)N(C[C@H](O)COc2ccccc2)C[C@H](O)COc2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 5/20 0.50
MAOB P27338 2/20 0.42
POLB P06746 2/20 0.41
LTB4R Q15722 3/20 0.41
LTB4R2 Q9NPC1 3/20 0.41
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 1/20 0.40
TSHR P16473 1/20 0.40
ADRB1 P08588 2/20 0.39
ADRB3 P13945 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9684062 1.00 ABCB1 (0.50) ABCB1MAOBPOLBLTB4RLTB4R2
SCHEMBL9683317 0.91 ABCB1 (0.47) ABCB1MAOBPOLBLTB4RLTB4R2
SCHEMBL9683321 0.91 ABCB1 (0.47) ABCB1MAOBPOLBLTB4RLTB4R2
SCHEMBL9683688 0.88 ABCB1 (0.55) ABCB1MAOBPOLBMAPTNPSR1
SCHEMBL9683677 0.88 ABCB1 (0.55) ABCB1MAOBPOLBMAPTNPSR1
SCHEMBL9811973 0.87 ABCB1 (0.56) ABCB1MAOBPOLBMAPTNPSR1
SCHEMBL9812089 0.87 ABCB1 (0.56) ABCB1MAOBPOLBMAPTNPSR1
SCHEMBL9811990 0.87 ABCB1 (0.56) ABCB1MAOBPOLBMAPTNPSR1
SCHEMBL9787412 0.86 ABCB1 (0.43) ABCB1MAOBLTB4RLTB4R2LMNA
SCHEMBL9787406 0.86 ABCB1 (0.43) ABCB1MAOBLTB4RLTB4R2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166218-A Antilipemic agents or antiglycemic agents HOFFMANN-LA ROCHE INC. (US) 1992-11-24 US claimed
EP-0140243-B1 PHENOXYPROPANOL AMINES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1988-11-09 EP claimed
US-5166218-A Antilipemic agents or antiglycemic agents HOFFMANN-LA ROCHE INC. (US) 1992-11-24 US disclosed
US-5064863-A Catabolic activity, obesity, diabetes HOFFMANN-LA ROCHE INC. (US) 1991-11-12 US disclosed